Zhishi Xiebai Guizhi Decoction modulates hypoxia and lipid toxicity to alleviate pulmonary vascular remodeling of pulmonary hypertension in rats
2024

Zhishi Xiebai Guizhi Decoction and Pulmonary Hypertension in Rats

Sample size: 50 publication 10 minutes Evidence: high

Author Information

Author(s): Fu Min, Li Yuan, Liu Jingjing, Liu Junjie, Wei Jiaoxia, Qiao Yuxin, Zhong Hanxin, Han Dongyang, Lu Haitao, Yao Li

Primary Institution: Harbin Medical University

Hypothesis

The study investigates the therapeutic potential of Zhishi Xiebai Guizhi Decoction (ZXGD) against pulmonary hypertension (PH) in rats.

Conclusion

ZXGD effectively alleviates pulmonary arterial pressure and pulmonary vascular remodeling in rats with pulmonary hypertension.

Supporting Evidence

  • ZXGD reduced pulmonary artery pressure in rats with pulmonary hypertension.
  • ZXGD modulated expressions of HIF-1α, ROS, and Nrf2 to alleviate hypoxia and oxidative stress.
  • ZXGD decreased levels of harmful lipids while increasing beneficial lipids.

Takeaway

This study shows that a traditional Chinese medicine called Zhishi Xiebai Guizhi Decoction can help treat high blood pressure in the lungs of rats.

Methodology

The study used chemical profiling, echocardiographic measurements, and various molecular biology techniques on rat models and cultured pulmonary artery smooth muscle cells.

Participant Demographics

Adult male Sprague Dawley rats, weight of 200±20 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/s13020-024-01039-0

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication